Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer

Purpose: Randomized trials examining neoadjuvant chemoradiotherapy followed by surgical resection (nCRT-S) and definitive CRT (dCRT) for esophageal cancer (EC) patients are hampered by use of nonstandard treatment paradigms. Outcomes of nCRT-S versus dCRT in a more common patient population are lack...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Häfner, Matthias (VerfasserIn) , Uzun-Lang, Kristin (VerfasserIn) , Körber, Stefan A. (VerfasserIn) , Uhlmann, Lorenz (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Sterzing, Florian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Strahlentherapie und Onkologie
Year: 2018, Jahrgang: 194, Heft: 2, Pages: 116-124
ISSN:1439-099X
DOI:10.1007/s00066-017-1211-0
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00066-017-1211-0
Verlag, Volltext: https://doi.org/10.1007/s00066-017-1211-0
Volltext
Verfasserangaben:Matthias Felix Haefner, Kristin Lang, Vivek Verma, Stefan Alexander Koerber, Lorenz Uhlmann, Juergen Debus, Florian Sterzing

MARC

LEADER 00000caa a2200000 c 4500
001 1581466420
003 DE-627
005 20240522085810.0
007 cr uuu---uuuuu
008 181001s2018 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00066-017-1211-0  |2 doi 
035 |a (DE-627)1581466420 
035 |a (DE-576)511466420 
035 |a (DE-599)BSZ511466420 
035 |a (OCoLC)1341019592 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Häfner, Matthias  |d 1983-  |e VerfasserIn  |0 (DE-588)101371993X  |0 (DE-627)664930042  |0 (DE-576)347618065  |4 aut 
245 1 0 |a Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer  |c Matthias Felix Haefner, Kristin Lang, Vivek Verma, Stefan Alexander Koerber, Lorenz Uhlmann, Juergen Debus, Florian Sterzing 
264 1 |c 2018 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.10.2018 
520 |a Purpose: Randomized trials examining neoadjuvant chemoradiotherapy followed by surgical resection (nCRT-S) and definitive CRT (dCRT) for esophageal cancer (EC) patients are hampered by use of nonstandard treatment paradigms. Outcomes of nCRT-S versus dCRT in a more common patient population are lacking. We investigated local control and survival, evaluated clinical factors associated with endpoints, and assessed patterns of failure between these cohorts.MethodsWe retrospectively analyzed 130 patients with locally advanced EC receiving either dCRT or nCRT-S at our institution from 2000-2012. Inclusion criteria were curatively treated nonmetastatic EC, Karnofsky performance status ≥70%, and receipt of concomitant CRT. Patients were excluded if receiving <41 Gy neoadjuvantly or <50 Gy definitively. Kaplan-Meier analysis was used to evaluate local recurrence (LR), progression-free survival (PFS), and overall survival (OS). Univariate and multivariate Cox proportional hazards modeling addressed factors associated with outcomes. Patterns of failure were enumerated as local, regional, or distant.ResultsMean follow-up was 34.2 months. The 3‑year LR was 10.8% in the nCRT-S group and 21.5% in the dCRT group (p = 0.266). Median PFS were 15.6 and 14.9 months, respectively (p = 0.549). Median OS were 20.6 and 25.9 months, respectively (p = 0.81). On univariate and multivariate analysis, none of the investigated factors was associated with outcomes, although node-positive disease showed a trend for worse OS and PFS. Most common failures in both groups were distant (dCRT 31.2% vs. nCRT-S 21.6%) followed by local in-field recurrences (dCRT 26.9% vs. nCRT-S 10.8%).ConclusionsIn this institutional analysis, no significant differences regarding outcomes and patterns of failure were observed between nCRT-S and dCRT. 
650 4 |a Esophagectomy 
650 4 |a local 
650 4 |a Lokalrezidiv einer Neoplasie 
650 4 |a Neoplasm recurrence 
650 4 |a Ösophagektomie 
650 4 |a Survival 
650 4 |a Therapieversagen 
650 4 |a Toxicity 
650 4 |a Toxizität 
650 4 |a Treatment failure 
650 4 |a Überleben 
700 1 |a Uzun-Lang, Kristin  |d 1986-  |e VerfasserIn  |0 (DE-588)106868237X  |0 (DE-627)820592064  |0 (DE-576)428008569  |4 aut 
700 1 |a Körber, Stefan A.  |e VerfasserIn  |0 (DE-588)1023031140  |0 (DE-627)717350053  |0 (DE-576)366291823  |4 aut 
700 1 |a Uhlmann, Lorenz  |d 1986-  |e VerfasserIn  |0 (DE-588)106747627X  |0 (DE-627)818782021  |0 (DE-576)426685660  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Sterzing, Florian  |d 1979-  |e VerfasserIn  |0 (DE-588)130141488  |0 (DE-627)492502722  |0 (DE-576)298021781  |4 aut 
773 0 8 |i Enthalten in  |t Strahlentherapie und Onkologie  |d Berlin : Springer Medizin, 1997  |g 194(2018), 2, Seite 116-124  |h Online-Ressource  |w (DE-627)312407866  |w (DE-600)2003907-4  |w (DE-576)090884809  |x 1439-099X  |7 nnas  |a Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer 
773 1 8 |g volume:194  |g year:2018  |g number:2  |g pages:116-124  |g extent:9  |a Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer 
856 4 0 |u http://dx.doi.org/10.1007/s00066-017-1211-0  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1007/s00066-017-1211-0  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181001 
993 |a Article 
994 |a 2018 
998 |g 130141488  |a Sterzing, Florian  |m 130141488:Sterzing, Florian  |p 7  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 6 
998 |g 106747627X  |a Uhlmann, Lorenz  |m 106747627X:Uhlmann, Lorenz  |d 910000  |d 910100  |e 910000PU106747627X  |e 910100PU106747627X  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1023031140  |a Körber, Stefan A.  |m 1023031140:Körber, Stefan A.  |d 910000  |d 911400  |e 910000PK1023031140  |e 911400PK1023031140  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 106868237X  |a Uzun-Lang, Kristin  |m 106868237X:Uzun-Lang, Kristin  |d 910000  |d 911400  |e 910000PU106868237X  |e 911400PU106868237X  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 101371993X  |a Häfner, Matthias  |m 101371993X:Häfner, Matthias  |d 910000  |d 911400  |e 910000PH101371993X  |e 911400PH101371993X  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1581466420  |e 3027506994 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Matthias Felix Haefner, Kristin Lang, Vivek Verma, Stefan Alexander Koerber, Lorenz Uhlmann, Juergen Debus, Florian Sterzing"]},"id":{"eki":["1581466420"],"doi":["10.1007/s00066-017-1211-0"]},"relHost":[{"pubHistory":["Nachgewiesen 173.1997 -"],"origin":[{"dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisherPlace":"Berlin ; Heidelberg ; [München]","publisher":"Springer Medizin ; Urban & Vogel"}],"note":["Gesehen am 13.05.09"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["ger"],"title":[{"subtitle":"journal of radiation oncology, biology, physics","title_sort":"Strahlentherapie und Onkologie","title":"Strahlentherapie und Onkologie"}],"part":{"text":"194(2018), 2, Seite 116-124","extent":"9","issue":"2","pages":"116-124","volume":"194","year":"2018"},"id":{"eki":["312407866"],"issn":["1439-099X"],"zdb":["2003907-4"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"312407866","disp":"Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancerStrahlentherapie und Onkologie"}],"person":[{"role":"aut","given":"Matthias","family":"Häfner","display":"Häfner, Matthias"},{"given":"Kristin","role":"aut","family":"Uzun-Lang","display":"Uzun-Lang, Kristin"},{"given":"Stefan A.","role":"aut","family":"Körber","display":"Körber, Stefan A."},{"role":"aut","given":"Lorenz","family":"Uhlmann","display":"Uhlmann, Lorenz"},{"family":"Debus","role":"aut","given":"Jürgen","display":"Debus, Jürgen"},{"family":"Sterzing","role":"aut","given":"Florian","display":"Sterzing, Florian"}],"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"title":[{"title_sort":"Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer","title":"Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer"}],"note":["Gesehen am 01.10.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1581466420","physDesc":[{"extent":"9 S."}]} 
SRT |a HAEFNERMATNEOADJUVAN2018